1- (1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3 Mimo> 98.0% (HPLC) Brexpiprazole Ile-iṣẹ agbedemeji

Apejuwe kukuru:

1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride

CAS: 913614-18-3

Mimọ:> 99.0% (HPLC)

Irisi: Funfun si Paa-White Powder

Agbedemeji ti Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Orukọ Kemikali 1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride
Awọn itumọ ọrọ sisọ Brexpiprazole Intermediate 2;1-Benzo [b] Thien-4-yl-Piperazine Hydrochloride;1-Benzo [b] Thien-4-ylpiperazine Monohydrochloride
Nọmba CAS 913614-18-3
NỌMBA CAT RF-PI1034
Iṣura Ipo Ninu Iṣura, Agbara iṣelọpọ 100MT / Ọdun
Ilana molikula C12H15ClN2S
Òṣuwọn Molikula 254.7789
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Funfun to Pa-White Powder
Idanimọ Akoko idaduro ti ayẹwo ni ibamu si ti boṣewa itọkasi
Mimọ / Analysis Ọna > 99.0% (HPLC)
Pipadanu lori Gbigbe <0.50%
Omi (KF) <0.50%
Aloku lori Iginisonu <0.20%
Awọn nkan ti o jọmọ (HPLC)
Eyikeyi Olukuluku aimọ <0.50%
Lapapọ Awọn Aimọ <1.00%
Infurarẹẹdi julọ.Oniranran Ni ibamu si Eto
Proton NMR julọ.Oniranran Ni ibamu si Eto
Igbeyewo Standard Standard Enterprise
Lilo Agbedemeji ti Brexpiprazole (CAS: 913611-97-9)

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

1

FAQ:

Ohun elo:

1- (1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) jẹ agbedemeji ti Brexpiprazole (CAS: 913611-97-9).Brexpiprazole jẹ iru antipsychotic atypical.O jẹ agonist apa kan olugba dopamine D2.Gẹgẹbi oluyipada iṣẹ ṣiṣe serotonin-dopamine aramada, o le ṣee lo fun itọju schizophrenia, ati fun itọju ajunmọ fun ibanujẹ.O tun le pese ipa ati ifarada lori awọn itọju ajumọṣe ti iṣeto formajor depressive disorder(MDD).Oogun naa ṣe afihan profaili elegbogi alailẹgbẹ kan, ṣiṣe bi agonist apa kan ti serotonin 5-HT1A ati awọn olugba dopamine D2 ati bi antagonist kikun ti 5-HT2A ati awọn olugba noradrenaline α1B/2C, pẹlu isunmọ isọdọkan subnanomolar iru.Oogun naa, eyiti o ni idagbasoke nipasẹ Otsuka ati Lundbeck, ni a fọwọsi ni ọdun 2015 nipasẹ FDA fun itọju schizophrenia ati bi itọju alamọran fun ibanujẹ.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa